Literature DB >> 29333603

Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?

J P Thyssen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29333603     DOI： 10.1111/bjd.16330

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  13 in total

1.  Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.

Authors:  Roselie E Achten; Chantal Van Luijk; Lisa Van der Rijst; Daphne Bakker; Lotte Spekhorst; Nicolaas Zuithoff; Marie Schuttelaar; Geertruida Romeijn; Angelique Voorberg; Marijke Kamsteeg; Inge Haeck; Marlies De Graaf; Judith Thijs; Joke De Boer; Marjolein De Bruin-Weller
Journal:  Acta Derm Venereol       Date:  2022-03-11       Impact factor: 3.875

2.  Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.

Authors:  Alison D Treister; Cheryl Kraff-Cooper; Peter A Lio
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

3.  Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis.

Authors:  Tamara Quint; Patrick M Brunner; Christoph Sinz; Irene Steiner; Robin Ristl; Kornelia Vigl; Susanne Kimeswenger; Katharina Neubauer; Detlev Pirkhammer; Martin Zikeli; Wolfram Hoetzenecker; Norbert Reider; Christine Bangert
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

Review 4.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

Review 5.  A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis.

Authors:  Gaurav Agnihotri; Katherine Shi; Peter A Lio
Journal:  Drugs R D       Date:  2019-12

6.  Conjunctivitis in dupilumab clinical trials.

Authors:  B Akinlade; E Guttman-Yassky; M de Bruin-Weller; E L Simpson; A Blauvelt; M J Cork; E Prens; P Asbell; E Akpek; J Corren; C Bachert; I Hirano; J Weyne; A Korotzer; Z Chen; T Hultsch; X Zhu; J D Davis; L Mannent; J D Hamilton; A Teper; H Staudinger; E Rizova; G Pirozzi; N M H Graham; B Shumel; M Ardeleanu; A Wollenberg
Journal:  Br J Dermatol       Date:  2019-05-07       Impact factor: 9.302

7.  Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series.

Authors:  L E M de Wijs; N T Nguyen; A C M Kunkeler; T Nijsten; J Damman; D J Hijnen
Journal:  Br J Dermatol       Date:  2019-12-22       Impact factor: 9.302

8.  Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion.

Authors:  J P Thyssen; M S de Bruin-Weller; A S Paller; Y A Leshem; C Vestergaard; M Deleuran; A M Drucker; R Foelster-Holst; C Traidl-Hoffmann; K Eyerich; A Taieb; J C Su; T Bieber; M J Cork; L F Eichenfield; E Guttman-Yassky; A Wollenberg
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-05-06       Impact factor: 6.166

9.  Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis.

Authors:  D S Bakker; L F M Ariens; C van Luijk; J van der Schaft; J L Thijs; M L A Schuttelaar; F van Wijk; E F Knol; D M W Balak; M R van Dijk; M S de Bruin-Weller
Journal:  Br J Dermatol       Date:  2019-02-04       Impact factor: 9.302

10.  Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series.

Authors:  Seung Hui Seok; Ji Hae An; Jung U Shin; Hee Jung Lee; Dong Hyun Kim; Moon Soo Yoon; Hyun Jung Kim
Journal:  Allergy Asthma Immunol Res       Date:  2020-11       Impact factor: 5.764
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.